Verition Fund Management LLC
Position in RVMD — Revolution Medicines, Inc.
CIK 1454027
GREENWICH, CT
Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,697,500
-$4,382,873 QoQ
Shares Held
110,000
-41.9% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$9,725,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Verition Fund Management LLC holds $147,085,063 across 39 Biotechnology names. RVMD ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
802,293 | $42,296,886 | |
| 2 | ACLX |
Arcellx, Inc.
|
187,354 | $21,511,986 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
400,000 | $16,092,000 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,000,000 | $14,460,000 | |
| 5 | EVMN |
Evommune, Inc.
|
549,991 | $12,644,293 | |
| 6 | RVMD |
Revolution Medicines, Inc.
This page
|
110,000 | $10,697,500 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
527,338 | $4,466,552 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
55,000 | $3,198,250 |
All Filings in RVMD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,725,000 | 100,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $10,697,500 | 110,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,080,373 | 189,333 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,325,468 | 135,449 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,292,425 | 143,855 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $492,600 | 13,931 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $645,149 | 14,226 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $1,434,000 | 50,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $205,800 | 7,435 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||